Article - European Medical Journal

Continue

Articles

Hepatology
3 Mins
28 May 2019

Transjugular Intrahepatic Portosystemic Stent-Shunt (TIPSS) for Acute Variceal Bleeding: Has it Come of Age?

Despite the introduction of covered TIPSS, studies have not consistently demonstrated a survival benefit in secondary prevention…
Hepatology
6 Mins
28 May 2019

Management of Hepatitis C in People Who Inject Drugs: Some Practical Lessons from the Frontline of the Elimination Battle

One of the critical populations in this battle to achieve elimination is people who inject drugs (PWID), who in the UK represent 85% of the hepatitis C…
Hepatology
18 Mins
28 May 2019

Editor's Pick: Overview of Alpha-1 Antitrypsin Deficiency-Mediated Liver Disease

This review aims to give an overview and update our knowledge of AATD associated with liver disease and discusses possible new therapeutic strategies…
Hepatology
6 Mins
28 May 2019

Non-Invasive Imaging Modalities in Nonalcoholic Fatty Liver Disease: Where Do We Stand?

New imaging modalities are emerging and may potentially replace biopsy. This review discusses the different non-invasive imaging modalities…
Hepatology
7 Mins
28 May 2019

Predictors of Fibrosis Progression in Chronic Active Hepatitis C Related Nephropathy

The role of angiopoietin 2 (Ang-2) in HCV-related nephropathy and its relationship with platelet parameters and thrombopoietin (TPO) is evaluated in this…
Hepatology
9 Mins
28 May 2019

Overlap Syndrome with Autoimmune Hepatitis and Primary Sclerosing Cholangitis

The autoimmune liver diseases (AILD) have been categorised classically as either autoimmune hepatitis (AIH), primary sclerosing cholangitis (PSC)…
Hepatology
13 Mins
28 May 2019

Liver Fibrosis: A Clinical Update

Liver fibrosis is the common sequelae of chronic insult to the liver from any aetiology. The most common causes are alcohol-related, fatty liver disease…
Oncology
11 Mins
20 May 2019

A Review of Gene Expression Profiling in Early-Stage ER+/HER2- Breast Cancer With A Focus on The PAM50 Risk of Recurrence Assay

Over 70% of patients with early-stage breast cancer are diagnosed with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative…